Moderna and J&J Boosters
Yesterday, the FDA advisory panel recommended a booster dose of Moderna for those over 65, those at high risk for serious Covid-19 complications, and those at risk for exposure to Covid due to occupation such as teachers or health care workers. These are the same groups as the recent Pfizer booster approval. However, given the strength of the Moderna vaccine, it appears the booster dose will be approximately ½ the strength of the original vaccine.
Today, the advisory panel also recommended a booster dose for the Johnson and Johnson (J&J) vaccine. Their recommendation is broader for this booster vaccine stating anyone over 18 who received a first dose of J&J should receive a booster at least two months after the initial dose.
While it is very likely the CDC will affirm these recommendations in the very near future,
the formal authorization approval is still pending.
We will notify you when these boosters are formally approved. |